Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

IcelandBack to Iceland

Clinical trials in Reykjavik

27 clinical trials in Reykjavik, Iceland. Every trial is listed in the EU Clinical Trials Register and updated daily.

IcelandOur site in IcelandKliniskarRannsoknir.is(opens in a new tab)
Reykjavik at a glance
27
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

27 trials in Reykjavik

Open in trial search

Follicular lymphoma

Recruiting

Study on Rituximab, Lenalidomide, and Tafasitamab for Treating High-Risk and Low-Risk Follicular Lymphoma Patients

Registered drugNo placebo
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Lenalidomide
  • Sponsor:Karolinska University Hospital

Intensive care

Recruiting

Evaluation of enoxaparin, dalteparin, nadroparin, tinzaparin and human albumin in adults admitted to intensive care unit with acute critical illness

Registered drugNo placebo
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Dalteparin Sodium
  • Sponsor:Rigshospitalet

Bladder transitional cell carcinoma

Recruiting

Study on Mitomycin and BCG for Patients with Recurrent Non-Muscle Invasive Bladder Cancer

Registered drugNo placebo
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Mitomycin
  • Sponsor:Aarhus University

Rheumatoid arthritis

Recruiting

Study Comparing Conventional Therapy and Biologic Treatments for Early Rheumatoid Arthritis Using Hydroxychloroquine, Abatacept, and Azathioprine in Responsive Patients

Registered drugNo placebo
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:Karolinska Institutet

Hypertrophic cardiomyopathy

Recruiting

Study on the Long-Term Safety of Aficamten (CK-3773274) for Patients with Symptomatic Hypertrophic Cardiomyopathy

InvestigationalNo placebo
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Aficamten
  • Sponsor:Cytokinetics Inc.

Acute myeloid leukaemia

Recruiting

Study on Treating Acute Myeloid Leukemia in Children and Adolescents Using Gemtuzumab Ozogamicin and a Drug Combination

Registered drugNo placebo
Countries:IcelandIceland
  • Participants:0–17 years · 18–64 years
  • Substances:Cytarabine
  • Sponsor:Prinses Maxima Centrum voor Kinderoncologie B.V.

Acute myeloid leukaemia

Recruiting

Study on the Safety and Effectiveness of Quizartinib for Children with Newly Diagnosed FLT3-ITD Positive AML and Normal NPM1

InvestigationalNo placebo
Countries:IcelandIceland
  • Participants:0–17 years · 18–64 years
  • Substances:Quizartinib Dihydrochloride
  • Sponsor:Prinses Maxima Centrum voor Kinderoncologie B.V.

Atrial fibrillation+2

Recruiting

Study on Apixaban for Preventing Stroke in Patients with Atrial Fibrillation and Stage 5 Chronic Kidney Disease

Registered drugNo placebo
Countries:IcelandIceland
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Karolinska University Hospital

Acute lymphocytic leukaemia

Recruiting

Study on Tioguanine and Drug Combination for Patients Aged 0-45 with Newly Diagnosed Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:IcelandIceland
  • Participants:0–17 years · 18–64 years
  • Substances:Blinatumomab
  • Sponsor:Karolinska University Hospital

HIV infection

Not yet recruiting

Durable HIV-1 control with 10-1074-LS, 3BNC117-LS and nivolumab in adults on ART: a randomized double‑blind placebo‑controlled trial

Registered drug
Countries:IcelandIceland
  • Participants:18–64 years
  • Substances:Nivolumab
  • Sponsor:Region Midtjylland

Dyspepsia

Not yet recruiting

Comparing 7-Day and 4-Week Esomeprazole Treatment in Patients with Unexplained Dyspepsia

Registered drugNo placebo
Countries:IcelandIceland
  • Participants:18–64 years
  • Substances:Calcium Carbonate
  • Sponsor:Landspitali

Plasma cell myeloma

Not yet recruiting

Study on Treating Smoldering and Active Multiple Myeloma with Dexamethasone, Lenalidomide, and Carfilzomib for Patients in Iceland

Registered drugNo placebo
Countries:IcelandIceland
  • Participants:18–64 years
  • Substances:Carfilzomib
  • Sponsor:Landspitali

Other cities in Iceland

The busiest research cities in the country

All 2 cities in Iceland

Clinical research in Reykjavik

What the registry says about research in the country

01 Cardiovascular Research

Innovative trials exploring treatments for cardiovascular diseases, including studies on lipoprotein reduction and atherosclerosis prevention. Research focuses on reducing major cardiovascular events in high-risk patients.

  • Atherosclerotic Disease Management
  • Hypertrophic Cardiomyopathy
  • Post-Bypass Treatment Strategies

Studies aim to improve patient outcomes through targeted therapeutic approaches and preventive measures.

02 Oncology Studies

Comprehensive research into various cancer types, including lymphoma, breast cancer, and lung cancer treatments. Trials evaluate novel therapeutic combinations and targeted approaches.

  • Bladder Cancer Treatments
  • Multiple Myeloma Management
  • Advanced Lung Cancer Therapy

Focus on improving survival rates and developing more effective treatment protocols.

03 Hematology Research

Advanced studies in blood disorders, particularly focusing on acute myeloid leukemia and lymphoblastic leukemia. Specialized treatments for both adult and pediatric patients.

  • Pediatric Leukemia Protocols
  • Novel Immunotherapy Approaches
  • Targeted Molecular Therapies

Emphasis on improving survival rates and developing personalized treatment strategies.

Back to IcelandAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.